Insight Molecular Diagnostic

Penny Stocks Biotech Stocks Healthcare Stocks

$3.10

-0.18 (-5.49%)

As of Apr 1, 2:31 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +461.6% upside

Low Target $14.05

Average Target $17.41

High Target $26.42

Current Price $3.10

Current
$3.10

Target
$17.41

$14.05 $17.41 avg $26.42

Scenario Analysis

Bear Case

$14.05

353.2%

Low target

Base Case

$17.41

+461.6%

Avg target

Bull Case

$26.42

+752.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$15.94

-80.6% from high

52-Week Low

$11.01

+-71.8% from low

Target vs 52W High

$17.41

+9.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%